Literature DB >> 17534860

Analysis of erlotinib and its metabolites in rat tissue sections by MALDI quadrupole time-of-flight mass spectrometry.

Luca Signor1, Emmanuel Varesio, Roland F Staack, Volkmar Starke, Wolfgang F Richter, Gérard Hopfgartner.   

Abstract

A qualitative and quantitative analysis of erlotinib (RO0508231) and its metabolites was carried out on rat tissue sections from liver, spleen and muscle. Following oral administration at a dose of 5 mg/kg, samples were analyzed by matrix-assisted laser desorption ionization (MALDI) with mass spectrometry (MS) using an orthogonal quadrupole time-of-flight instrument. The parent compound was detected in all tissues analyzed. The metabolites following drug O-dealkylation could also be detected in liver sections. Sinapinic acid (SA) matrix combined with the dried-droplet method resulted in better conditions for our analysis on tissues. Drug quantitation was investigated by the standard addition method and liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis on the tissue extracts. The presence of the parent compound and of its O-demethylated metabolites was confirmed in all tissue types and their absolute amounts calculated. In liver the intact drug was found to be 3.76 ng/mg tissue, while in spleen and muscle 6- and 30-fold lower values, respectively, were estimated. These results were compared with drug quantitation obtained by whole-body autoradiography, which was found to be similar. The potential for direct quantitation on tissue sections in the presence of an internal standard was also investigated using MALDI-MS. The use of alpha-cyano-4-hydroxycinnamic acid (CHCA) as the matrix resulted in better linearity for the calibration curves obtained with reference solutions of the drug when compared to SA, but on tissue samples no reliable quantitative analysis was possible owing to the large variability in the signal response. MS imaging experiments using MALDI in MS/MS mode allowed visualizing the distribution of the parent compound in liver and spleen tissues. By calculating the ratio between the total ion intensities of MS images for liver and spleen sections, a value of 6 : 1 was found, which is in good agreement with the quantitative data obtained by LC-MS/MS analysis. Copyright (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17534860     DOI: 10.1002/jms.1225

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  29 in total

Review 1.  Mass spectrometry imaging for drugs and metabolites.

Authors:  Tyler Greer; Robert Sturm; Lingjun Li
Journal:  J Proteomics       Date:  2011-04-13       Impact factor: 4.044

Review 2.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

Review 3.  Molecular imaging by mass spectrometry--looking beyond classical histology.

Authors:  Kristina Schwamborn; Richard M Caprioli
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

4.  Simultaneous detection of intracellular target and off-target binding of small molecule cancer drugs at nanomolar concentrations.

Authors:  Heike Glauner; Ivo R Ruttekolk; Kerrin Hansen; Ben Steemers; Yi-Da Chung; Frank Becker; Stefan Hannus; Roland Brock
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

5.  Biosynthetic origin of natural products isolated from marine microorganism-invertebrate assemblages.

Authors:  T Luke Simmons; R Cameron Coates; Benjamin R Clark; Niclas Engene; David Gonzalez; Eduardo Esquenazi; Pieter C Dorrestein; William H Gerwick
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

Review 6.  Qualitative and quantitative mass spectrometry imaging of drugs and metabolites in tissue at therapeutic levels.

Authors:  Na Sun; Axel Walch
Journal:  Histochem Cell Biol       Date:  2013-07-24       Impact factor: 4.304

7.  Comprehensive identification of proteins from MALDI imaging.

Authors:  Stefan K Maier; Hannes Hahne; Amin Moghaddas Gholami; Benjamin Balluff; Stephan Meding; Cédrik Schoene; Axel K Walch; Bernhard Kuster
Journal:  Mol Cell Proteomics       Date:  2013-06-19       Impact factor: 5.911

8.  MALDI-FTICR imaging mass spectrometry of drugs and metabolites in tissue.

Authors:  Dale S Cornett; Sara L Frappier; Richard M Caprioli
Journal:  Anal Chem       Date:  2008-06-20       Impact factor: 6.986

9.  Development and validation of a spectrofluorimetric method for the determination of erlotinib in spiked human plasma.

Authors:  Bivash Mandal; Pavan Balabathula; Nivesh Mittal; George C Wood; Himanshu Bhattacharjee
Journal:  J Fluoresc       Date:  2012-08-09       Impact factor: 2.217

Review 10.  Imaging of intact tissue sections: moving beyond the microscope.

Authors:  Erin H Seeley; Kristina Schwamborn; Richard M Caprioli
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.